BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8390600)

  • 1. Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood.
    Vecchi V; Burnelli R; Pileri S; Rosito P; Sabattini E; Civino A; Pericoli R; Paolucci G
    Med Pediatr Oncol; 1993; 21(6):402-10. PubMed ID: 8390600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.
    Greer JP; Kinney MC; Collins RD; Salhany KE; Wolff SN; Hainsworth JD; Flexner JM; Stein RS
    J Clin Oncol; 1991 Apr; 9(4):539-47. PubMed ID: 1648596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
    Shulman LN; Frisard B; Antin JH; Wheeler C; Pinkus G; Magauran N; Mauch P; Nobles E; Mashal R; Canellos G
    J Clin Oncol; 1993 May; 11(5):937-42. PubMed ID: 8387578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
    Kinney MC; Collins RD; Greer JP; Whitlock JA; Sioutos N; Kadin ME
    Am J Surg Pathol; 1993 Sep; 17(9):859-68. PubMed ID: 8394652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
    Tomaszewski MM; Moad JC; Lupton GP
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 expression in non-Hodgkin's lymphoma.
    Piris M; Brown DC; Gatter KC; Mason DY
    Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
    Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
    Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Tsurumi H; Takahashi T; Moriwaki H; Muto Y
    Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35).
    Bitter MA; Franklin WA; Larson RA; McKeithan TW; Rubin CM; Le Beau MM; Stephens JK; Vardiman JW
    Am J Surg Pathol; 1990 Apr; 14(4):305-16. PubMed ID: 2157342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
    Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoral presentation of anaplastic large-cell Ki-1 lymphoma in association with HIV infection.
    Hicks MJ; Flaitz CM; Nichols CM; Luna MA; Gresik MV
    Oral Surg Oral Med Oral Pathol; 1993 Jul; 76(1):73-81. PubMed ID: 8394561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Thaler HT; Polyak T; Cranor ML; Wollner N
    Cancer; 2000 Jan; 88(1):186-97. PubMed ID: 10618623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
    Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
    Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialosylated Lewis chi expression in CD30-positive anaplastic large-cell lymphomas.
    Kasai K; Sato Y; Kuwao S; Kawakubo Y; Inoue H; Kameya T
    J Cancer Res Clin Oncol; 1992; 119(2):87-90. PubMed ID: 1358895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
    Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
    Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol.
    Rosolen A; Pillon M; Garaventa A; Burnelli R; d'Amore ES; Giuliano M; Comis M; Cesaro S; Tettoni K; Moleti ML; Tamaro P; Visintin G; Zanesco L
    Cancer; 2005 Nov; 104(10):2133-40. PubMed ID: 16211546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinction of Hodgkin's disease from anaplastic large cell lymphoma.
    Frizzera G
    Semin Diagn Pathol; 1992 Nov; 9(4):291-6. PubMed ID: 1480851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.